Abiraterone acetate (Yonsa®) Patient Selection and Management

This PQI in Action highlights how multidisciplinary oncology teams use the Yonsa® (abiraterone acetate) PQI to improve care for patients with advanced prostate cancer. Featuring insights from AtlantiCare Cancer Care Institute and Cancer Specialists of North Florida, the article shows how medically integrated pharmacy teams streamline access, educate patients, manage side effects, and ensure safe, effective, and patient-centered treatment.